Lockshin Curtis 4
4 · Xenetic Biosciences, Inc. · Filed Mar 28, 2022
Insider Transaction Report
Form 4
Lockshin Curtis
Chief Scientific Officer
Transactions
- Award
Stock Options
2022-03-24+50,000→ 50,000 totalExercise: $1.12Exp: 2032-03-24→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025.